Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (123)

« Back to Publications

Data from ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial

Blanc-Durand F. et al, (2026)

Supplementary Table S1 from ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial

Blanc-Durand F. et al, (2026)

ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial

Blanc-Durand F. et al, (2026), Clinical Cancer Research, 32, 963 - 969

Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types

Everall A. et al, (2026), Nature Genetics

Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority Trial.

Iveson T. et al, (2026), Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Supplementary Figure S3 from Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level

Brummel K. et al, (2025)

Supplementary Table 2 from Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level

Brummel K. et al, (2025)

Data from Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level

Brummel K. et al, (2025)

Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level

Brummel K. et al, (2025), Cancer Immunology Research, 13, 1911 - 1924

Supplementary Figure S4 from Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level

Brummel K. et al, (2025)

Supplementary Table 1 from Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level

Brummel K. et al, (2025)

Supplementary Figure S5 from Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level

Brummel K. et al, (2025)

Supplementary Figure S1 from Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level

Brummel K. et al, (2025)

Supplementary Figure S2 from Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level

Brummel K. et al, (2025)

Replication-associated mechanisms contribute to an increased CpG > TpG mutation burden in mismatch repair-deficient cancers

Ward JC. et al, (2025), Genome Medicine, 17

Load More

1
2
3
4
5
6
7
...
»